Amgen Inc. (AMGN)
NASDAQ · Healthcare
Amgen Inc. EBITDA 2007–2025
Amgen Inc. annual/quarterly ebitda history and growth rate from 2007 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Amgen Inc. ebitda for the quarter ending March 31, 2026 was 3.8 B, a 47.45% increase year-over-year.
- Amgen Inc. ebitda for the twelve months ending March 31, 2026 was 12.0 B, a 25.23% increase year-over-year.
- Amgen Inc. annual ebitda for 2025 was 14.2 B, a 10.87% increase from 2024.
- Amgen Inc. annual ebitda for 2024 was 12.8 B, a 7.37% increase from 2023.
- Amgen Inc. annual ebitda for 2023 was 12.0 B, a 7.82% decrease from 2022.
- Amgen Inc. annual ebitda for 2022 was 13.0 B.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amgen Inc. EBITDA — FAQ
Amgen Inc. (AMGN) ebitda over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMGN's ebitda history?
The chart and table above show Amgen Inc.'s ebitda by year and by quarter, including the growth rate.